CLOV
Clover Health Investments, Corp. NASDAQ Listed Jun 12, 2020$4.22
-1.17%
vs $4.27
Mkt Cap $2.2B
52w Low $1.58
65.8% of range
52w High $5.59
50d MA $4.53
200d MA $2.99
P/E (TTM)
—
EV/EBITDA
—
P/B
7.1x
Debt/Equity
0.0x
ROE
-26.5%
P/FCF
-32.0x
RSI (14)
40.30
ATR (14)
$0.23
Beta
2.25
50d MA
$4.53
200d MA
$2.99
Avg Volume
5.5M
Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.
725 Cool Springs Blvd · Franklin, TN 37067 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | AMC | 0.07 | 0.07 | +0.0% | 2.68 | +3.0% | +5.2% | +10.6% | +2.6% | +2.5% | +8.2% | — |
| Feb 26, 2026 | AMC | -0.10 | -0.05 | +51.0% | 2.15 | -4.2% | -2.8% | -2.4% | -2.0% | +8.0% | -4.2% | — |
| Nov 4, 2025 | AMC | 0.02 | -0.05 | -350.0% | 3.52 | -19.9% | -15.6% | -12.1% | +2.3% | -2.6% | -1.9% | — |
| Aug 5, 2025 | AMC | 0.03 | 0.03 | +0.0% | 2.85 | -18.2% | -20.7% | -2.2% | -1.4% | +13.3% | +1.2% | — |
| May 6, 2025 | AMC | -0.07 | 0.05 | +171.4% | 3.35 | +3.0% | +12.5% | -0.5% | -6.4% | -1.1% | -2.0% | — |
| Mar 11, 2025 | AMC | -0.07 | -0.04 | +42.9% | 3.36 | +3.9% | +7.4% | -4.2% | +5.8% | +1.1% | +3.0% | — |
| Feb 27, 2025 | AMC | -0.07 | -0.04 | +42.9% | 4.14 | -3.6% | -4.1% | -8.3% | +2.2% | +3.0% | -4.2% | — |
| Nov 6, 2024 | AMC | -0.01 | -0.02 | -50.3% | 4.35 | -10.6% | -15.6% | -7.1% | -2.3% | -2.4% | -2.8% | — |
| Aug 5, 2024 | AMC | -0.05 | 0.01 | +120.0% | 1.88 | +6.4% | -2.7% | -8.7% | +9.6% | +1.6% | +0.5% | — |
| May 7, 2024 | AMC | -0.07 | -0.05 | +28.6% | 0.74 | +19.5% | +17.6% | -0.8% | -5.0% | +11.2% | +11.9% | — |
| Mar 12, 2024 | AMC | -0.18 | -0.12 | +33.3% | 0.77 | +10.7% | +5.0% | -10.0% | +10.0% | -1.8% | +4.9% | — |
| Nov 6, 2023 | AMC | -0.10 | -0.09 | +10.0% | 1.13 | -15.3% | -18.2% | -2.4% | -2.1% | +2.3% | -0.4% | — |
| Aug 8, 2023 | AMC | -0.13 | -0.06 | +53.8% | 1.33 | +10.5% | +4.5% | -5.0% | +13.6% | +4.0% | -9.0% | — |
| May 9, 2023 | AMC | -0.19 | -0.15 | +21.1% | 0.93 | -0.4% | -1.3% | +3.6% | +2.6% | -0.3% | +3.9% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20 | Canaccord Genuity | Maintains | Buy → Buy | — | $1.89 | $1.91 | +1.1% | +0.0% | -2.1% | -1.6% | +0.0% | -1.1% |
| Mar 5 | Leerink Partners | Maintains | Market Perform → Market Perform | — | $2.16 | $2.16 | +0.0% | -4.2% | -3.4% | +0.0% | -0.5% | +1.5% |
| Jan 20 | Canaccord Genuity | Maintains | Buy → Buy | — | $2.54 | $2.50 | -1.6% | +2.0% | +1.2% | +2.3% | -3.4% | -3.9% |
| Nov 6 | Canaccord Genuity | Maintains | Buy → Buy | — | $2.97 | $2.99 | +0.7% | -12.1% | +2.3% | -2.6% | -1.9% | -1.6% |
| Aug 7 | Canaccord Genuity | Maintains | Buy → Buy | — | $2.26 | $2.29 | +1.3% | -2.2% | -1.4% | +13.3% | +1.2% | +4.8% |
| Aug 6 | UBS | Maintains | Neutral → Neutral | — | $2.85 | $2.33 | -18.2% | -20.7% | -2.2% | -1.4% | +13.3% | +1.2% |
| Mar 3 | Canaccord Genuity | Maintains | Buy → Buy | — | $3.97 | $3.96 | -0.3% | -8.3% | +2.2% | +3.0% | -4.2% | -0.8% |
| Aug 11 | Citigroup | Maintains | Neutral → Neutral | — | $1.32 | $1.30 | -1.5% | +13.6% | +4.0% | -9.0% | -0.7% | -2.8% |
| Mar 6 | Credit Suisse | Maintains | Underperform → Underperform | — | $1.09 | $1.08 | -0.9% | -11.0% | +5.1% | -4.0% | -2.4% | -4.4% |
| Mar 6 | Canaccord Genuity | Maintains | Buy → Buy | — | $1.09 | $1.08 | -0.9% | -11.0% | +5.1% | -4.0% | -2.4% | -4.4% |
| Nov 16 | Citigroup | Maintains | Neutral → Neutral | — | $1.47 | $1.45 | -1.4% | -6.8% | -6.6% | +3.9% | -6.8% | +0.8% |
| Nov 8 | SVB Leerink | Maintains | Market Perform → Market Perform | — | $1.36 | $1.37 | +0.7% | -5.1% | -4.7% | +13.8% | +9.3% | -3.3% |
| Aug 9 | Citigroup | Maintains | Neutral → Neutral | — | $3.40 | $2.92 | -14.1% | -17.9% | +10.0% | +1.3% | +6.1% | -1.5% |
| Aug 9 | Credit Suisse | Maintains | Underperform → Underperform | — | $3.40 | $2.92 | -14.1% | -17.9% | +10.0% | +1.3% | +6.1% | -1.5% |
| May 10 | SVB Leerink | Maintains | Market Perform → Market Perform | — | $2.41 | $2.76 | +14.5% | -1.7% | -10.1% | +7.5% | +14.0% | -0.8% |
| Feb 25 | SVB Leerink | Maintains | Market Perform → Market Perform | — | $2.45 | $2.40 | -2.0% | +2.9% | +7.9% | -0.4% | -1.5% | -11.6% |
| Feb 2 | TD Cowen | Upgrade | Underperform → Market Perform | — | $2.79 | $3.03 | +8.6% | -1.4% | -7.3% | +3.9% | -1.1% | +5.3% |
| Jan 7 | Credit Suisse | Downgrade | Neutral → Underperform | — | $3.35 | $3.31 | -1.2% | -5.7% | +1.6% | +3.1% | -4.2% | -3.2% |
| Nov 15 | Credit Suisse | Maintains | Neutral → Neutral | — | $7.16 | $7.28 | +1.7% | +5.6% | -8.2% | -7.3% | -12.8% | +2.5% |
| Jul 12 | JP Morgan | Downgrade | Neutral → Underweight | — | $9.27 | $9.15 | -1.3% | +4.4% | -8.0% | -2.6% | -4.8% | -0.7% |
| Jun 10 | BofA Securities | Downgrade | Neutral → Underperform | — | $16.92 | $18.09 | +6.9% | -15.2% | +4.8% | -2.5% | -6.1% | -6.0% |
| May 19 | Credit Suisse | Maintains | Neutral → Neutral | — | $6.97 | $6.74 | -3.3% | -1.9% | +4.2% | -2.8% | -0.1% | +1.4% |
| May 17 | BofA Securities | Downgrade | Buy → Neutral | — | $7.47 | $7.59 | +1.6% | -8.7% | +2.2% | -1.9% | +4.2% | -2.8% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jul 20, 2026 | Soares KarenOff | Chief Legal Officer | Sell | 51,700 | $4.51 | $233K | 1,505,522 | +6.44% | -1.16% |
| Jul 15, 2026 | THORNTON JOSEPH CLAYOff | Interim CFO | Sell | 4,630 | $4.67 | $22K | 1,212,954 | +5.00% | -2.57% |
| Jul 15, 2026 | Soares KarenOff | Chief Legal Officer | Sell | 10,519 | $4.67 | $49K | 1,557,222 | +5.00% | -2.57% |
| Jul 15, 2026 | Reynoso Jamie L.Off | CEO, Medicare Advantage | Sell | 13,119 | $4.67 | $61K | 2,819,479 | +5.00% | -2.57% |
| Jul 15, 2026 | Wai ConradOff | CEO, Counterpart Health | Sell | 24,215 | $4.67 | $113K | 1,145,699 | +5.00% | -2.57% |
| Jul 15, 2026 | Toy AndrewDir/Off | Chief Executive Officer | Sell | 62,711 | $4.67 | $293K | 9,547,114 | +5.00% | -2.57% |
| Jul 8, 2026 | Reynoso Jamie L.Off | CEO, Medicare Advantage | Sell | 2,384 | $4.68 | $11K | 2,832,598 | -5.13% | -5.98% |
| Jul 6, 2026 | Reynoso Jamie L.Off | CEO, Medicare Advantage | Sell | 6,229 | $5.26 | $33K | 2,834,982 | -1.19% | +2.93% |
| Jul 1, 2026 | Toy AndrewDir/Off | Chief Executive Officer | Sell | 313,476 | $5.32 | $1.7M | 9,609,825 | -2.41% | +0.43% |
| Jun 17, 2026 | Reynoso Jamie L.Off | CEO, Medicare Advantage | Sell | 2,360 | $4.78 | $11K | 2,841,211 | +2.80% | +3.84% |
| Jun 16, 2026 | OLDAKOWSKI JOSEPH FRANKOff | VP OF FINANCE AND CONTROLLER | Sell | 12,102 | $4.86 | $59K | 299,067 | +4.17% | +0.00% |
| Jun 15, 2026 | Soares KarenOff | Chief Legal Officer | Sell | 4,681 | $4.61 | $22K | 1,567,741 | -2.83% | +2.96% |
| Jun 15, 2026 | Reynoso Jamie L.Off | CEO, Medicare Advantage | Sell | 6,350 | $4.61 | $29K | 2,843,571 | -2.83% | +2.96% |
| Jun 11, 2026 | Reynoso Jamie L.Off | CEO, Medicare Advantage | Sell | 7,289 | $4.91 | $36K | 2,849,921 | -3.47% | +4.17% |
| May 28, 2026 | Wai ConradOff | CEO, Counterpart Health | Sell | 220,426 | $3.99 | $879K | 1,390,056 | -4.78% | +9.32% |
| May 18, 2026 | Edwards Carladenise ArmbristerDir | — | Sell | 67,160 | $3.42 | $230K | 285,432 | +2.57% | -0.55% |
| May 13, 2026 | Priest Brady PatrickOff | CEO of Clover Care Services | Sell | 98,039 | $3.52 | $345K | 2,040,222 | -1.69% | +2.57% |
8-K · 8.01
!! High
Clover Health Investments, Corp. -- 8-K 8.01: Material Event / Announcement
Jul 17
8-K · 8.01
!! High
Clover Health Investments, Corp. -- 8-K 8.01: Material Event / Announcement
Clover Health received CMS notification regarding a court judgment affecting Clover Insurance Co., likely impacting the company's Medicare Advantage operations and regulatory standing.
Jun 18
8-K · 5.02
!!! Very High
Clover Health Investments, Corp. -- 8-K 5.02: Executive Change
Brady Priest stepped down as Clover Health CEO but remains on the board as director, signaling a leadership transition while maintaining his involvement in strategic oversight.
Jun 16
8-K
Clover Health Investments, Corp. -- 8-K Filing
Jun 12
8-K · 8.01
!! High
Clover Health Investments, Corp. -- 8-K 8.01: Material Event / Announcement
Clover Health's insurance subsidiary won partial summary judgment in its federal lawsuit against HHS, potentially reducing regulatory liability and supporting the company's healthcare operations going forward.
Jun 10
8-K · 7.01
! Medium
Clover Health Investments, Corp. -- 8-K 7.01: Regulation FD Disclosure
Clover Health provided supplemental written responses to investor questions, disclosing additional information through an 8-K filing to ensure fair information distribution to all investors.
May 18
8-K · 2.02
!! High
Clover Health Investments, Corp. -- 8-K 2.02: Earnings Results
Clover Health reported Q1 2026 financial results on May 6, revealing the company's operational performance and financial condition to investors.
May 6
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Clover Health's executive leadership transition on March 30, 2026 signals potential strategic shifts in company direction, requiring investors to monitor whether replacement leadership can improve operational performance and profitability.
Apr 1
8-K · 7.01
! Medium
Clover Health Investments, Corp -- 8-K 7.01: Regulation FD Disclosure
Clover Health (CLOV) disclosed supplemental Q&A responses via Form 8-K, providing investors updated company information available on its investor relations website.
Mar 6
8-K · 7.01
! Medium
Clover Health Investments, Corp -- 8-K 7.01: Regulation FD Disclosure
Clover Health disclosed supplemental Q&A responses via 8-K filing, providing investors additional transparency on company operations and strategy through publicly available investor relations materials.
Mar 6
8-K
Clover Health Investments, Corp -- 8-K Filing
Clover Health Investments (CLOV) filed its required 8-K report on February 26, 2026, maintaining SEC compliance and transparency with investors regarding material corporate developments.
Feb 26
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management Llc | 16,982,073 | $30M | New | Mar 2026 |
| 2 | Morgan Stanley | 5,198,056 | $12M | Added | Dec 2025 |
| 3 | Pnc Financial Services Group, Inc. | 3,764,034 | $7M | — | Mar 2026 |
| 4 | Vanguard Portfolio Management Llc | 3,696,437 | $7M | New | Mar 2026 |
| 5 | Renaissance Technologies Llc | 3,401,541 | $6M | Reduced | Mar 2026 |
| 6 | Northern Trust Corp | 3,306,575 | $6M | Added | Mar 2026 |
| 7 | Citadel Advisors Llc | 1,878,048 | $3M | Added | Mar 2026 |
| 8 | Ubs Group Ag | 1,767,799 | $3M | Added | Mar 2026 |
| 9 | Hrt Financial Lp | 1,667,691 | $3M | New | Mar 2026 |
| 10 | Millennium Management | 1,164,968 | $2M | New | Mar 2026 |
| 11 | Bank Of New York Mellon Corp | 1,138,127 | $2M | Reduced | Mar 2026 |
| 12 | Invesco Ltd. | 1,028,371 | $2M | Added | Mar 2026 |
| 13 | Principal Financial Group Inc | 709,482 | $2M | Added | Dec 2025 |
| 14 | Nuveen, Llc | 935,543 | $2M | Added | Mar 2026 |
| 15 | Susquehanna International Group, Llp | 898,557 | $2M | Reduced | Mar 2026 |
| 16 | Jane Street Group, Llc | 586,497 | $1M | Reduced | Dec 2025 |
| 17 | Point72 Asset Management | 503,005 | $885K | New | Mar 2026 |
| 18 | California State Teachers Retirement System | 497,006 | $875K | New | Mar 2026 |
| 19 | Bank Of America Corp /de/ | 371,114 | $653K | Added | Mar 2026 |
| 20 | Jpmorgan Chase & Co | 337,095 | $580K | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$2.19B
Enterprise Value
$2.11B
P/E (TTM)
—
Forward P/E
98.60x
PEG Ratio
-0.15x
P/B
7.07x
P/S
0.99x
P/FCF
-32.02x
EV/EBITDA
—
Shares Out
517.2M
Financials (TTM)
Revenue
$2.21B
Net Income
-$56.9M
EBITDA
-$55.2M
Free Cash Flow
-$69.0M
Op Cash Flow
-$66.9M
EPS Basic
$-0.17
EPS Diluted
$-0.11
EPS Forward
$0.04
Gross Margin
18.4%
Op Margin
-2.6%
Net Margin
-2.6%
Balance Sheet
Total Assets
$541.0M
Total Liab.
$232.3M
Total Equity
$308.7M
Cash
$95.3M
LT Debt
$0
Book Value/Sh
$0.60
Debt/Equity
0.00x
Current Ratio
1.47
Quick Ratio
1.47
Returns & Growth
ROE
-26.5%
ROA
-15.8%
ROIC
-25.8%
Rev Growth YoY
+40.3%
EPS Growth YoY
-93.6%
Price Returns
2W
-10.9%
1M
-15.6%
3M
+63.6%
6M
+109.3%
12M
+49.8%
Technicals
52W High
$5.59
52W Low
$1.58
50d MA
$4.53
200d MA
$2.99
RSI (14)
40.30
ATR (14)
$0.23
Beta
2.25
Avg Volume
5.5M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$3.33
High
$6.00
Low
$1.80
Median
$2.75
Data updated apr 25, 2026 1:44am
· Source: financialmodelingprep.com